TW201103914A - Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors - Google Patents

Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors Download PDF

Info

Publication number
TW201103914A
TW201103914A TW099112745A TW99112745A TW201103914A TW 201103914 A TW201103914 A TW 201103914A TW 099112745 A TW099112745 A TW 099112745A TW 99112745 A TW99112745 A TW 99112745A TW 201103914 A TW201103914 A TW 201103914A
Authority
TW
Taiwan
Prior art keywords
compound
group
isobutyl
xyz
phenyl
Prior art date
Application number
TW099112745A
Other languages
English (en)
Chinese (zh)
Inventor
Christopher M Flores
Marina I Nelen
Erica L Nulton
Steven Prouty
Matthew Todd
Sui-Po Zhang
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of TW201103914A publication Critical patent/TW201103914A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
TW099112745A 2009-04-22 2010-04-22 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors TW201103914A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17166109P 2009-04-22 2009-04-22

Publications (1)

Publication Number Publication Date
TW201103914A true TW201103914A (en) 2011-02-01

Family

ID=42226535

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099112745A TW201103914A (en) 2009-04-22 2010-04-22 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors

Country Status (11)

Country Link
EP (1) EP2421535A1 (fr)
JP (1) JP2012524810A (fr)
KR (1) KR20120005517A (fr)
CN (1) CN102458407B (fr)
AU (1) AU2010238746B2 (fr)
BR (1) BRPI1014874A2 (fr)
CA (1) CA2759706A1 (fr)
IL (1) IL215797A0 (fr)
RU (1) RU2011147201A (fr)
TW (1) TW201103914A (fr)
WO (1) WO2010124122A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2760450A1 (fr) * 2011-09-30 2014-08-06 Janssen Pharmaceutica, N.V. Inhibiteurs de monoacylglycérol lipase pour le traitement de maladies métaboliques et de troubles apparentés
EP2935294A4 (fr) 2012-12-21 2016-08-31 Univ California Méthodes et compositions pour le traitement de la toxicité du cyanure et de sulfure d'hydrogène
JP6454349B2 (ja) * 2013-12-26 2019-01-16 武田薬品工業株式会社 モノアシルグリセロールリパーゼ（ｍａｇｌ）阻害剤としての４−（ピペラジン−１−イル）−ピロリジン−２−オン化合物
WO2016158956A1 (fr) * 2015-03-30 2016-10-06 武田薬品工業株式会社 Composé hétérocyclique
US10463753B2 (en) 2016-02-19 2019-11-05 Lundbeck La Jolla Research Center, Inc. Radiolabeled monoacylglycerol lipase occupancy probe
BR112018068538B1 (pt) 2016-03-31 2023-12-12 Takeda Pharmaceutical Company Limited Composto, medicamento, e, uso de um composto
WO2017170830A1 (fr) 2016-03-31 2017-10-05 武田薬品工業株式会社 Composé hétérocyclique
MX2020007318A (es) 2017-09-29 2020-08-24 Takeda Pharmaceuticals Co Compuesto heterociclico.
EP3717477B1 (fr) 2017-11-28 2022-07-20 F. Hoffmann-La Roche AG Nouveaux composés hétérocycliques
TW201930300A (zh) * 2017-12-15 2019-08-01 瑞士商赫孚孟拉羅股份公司 新雜環化合物
EP3856178A1 (fr) * 2018-09-28 2021-08-04 Janssen Pharmaceutica NV Modulateurs de la monoacylglycérol lipase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2915199B1 (fr) * 2007-04-18 2010-01-22 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
EP2180048B1 (fr) * 2008-10-09 2014-12-17 Janssen Pharmaceutica N.V. Forme cristalline alternative de la monoacylglycérol lipase (MGLL)

Also Published As

Publication number Publication date
CN102458407B (zh) 2014-03-05
KR20120005517A (ko) 2012-01-16
AU2010238746B2 (en) 2015-02-19
WO2010124122A1 (fr) 2010-10-28
CN102458407A (zh) 2012-05-16
IL215797A0 (en) 2012-01-31
JP2012524810A (ja) 2012-10-18
BRPI1014874A2 (pt) 2016-04-12
CA2759706A1 (fr) 2010-10-28
RU2011147201A (ru) 2013-05-27
AU2010238746A1 (en) 2011-11-10
EP2421535A1 (fr) 2012-02-29

Similar Documents

Publication Publication Date Title
TW201103914A (en) Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
TWI495637B (zh) 用作單醯基甘油脂肪酶抑制劑之雜芳族及芳族六氫吡基吖丁啶基醯胺（一）
JP2013540159A (ja) モノアシルグリセロールリパーゼ阻害剤としてのピペリジン−４−イル−アゼチジンジアミド
US8759533B2 (en) Di-azetidinyl diamide as monoacylglcerol lipase inhibitors
CN103415289B (zh) 前神经原性化合物
US8637498B2 (en) Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
CN103261189B (zh) 作为单酰基甘油脂肪酶抑制剂的氨基-吡咯烷-氮杂环丁烷二酰胺
TW201242965A (en) Ring-fused heterocyclic derivative
TW201028386A (en) Novel bicyclic heterocyclic compound
CN108329253A (zh) 前神经原性化合物
CN1446217A (zh) 用作磷酸二酯酶抑制剂的β－咔啉衍生物
JP2011516442A (ja) 筋ジストロフィーを治療するための化合物
CN101061123A (zh) 噻吩并吡啶酮化合物及治疗方法
JP2014528428A (ja) 代謝症及び関連障害の治療のためのモノアシルグリセロールリパーゼ阻害剤
US20130102584A1 (en) Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
US20220226508A1 (en) Methods and compositions for treating epilepsy
WO2019034153A1 (fr) Composé chimique, composition pharmaceutique de celui-ci, utilisation et application correspondantes
CN100345843C (zh) 4－(硫代呫吨－9－亚基)－哌啶或吖啶的衍生物及其在制备药物中的应用
US5792760A (en) Bisindoles as tachykinin receptor antagonists
WO1997038692A1 (fr) Binsindoles pour traiter la douleur ou les phenomenes nociceptifs
KR101770619B1 (ko) 지방산 아미드 하이드롤라제의 조절제
US10519105B2 (en) KCNQ2-5 channel activator
TW202325305A (zh) ２－（芳基－２－基）嗎啉及其氘代衍生物、製備方法和應用
CN1732004A (zh) 用jnk抑制剂治疗疼痛
TW201313702A (zh) 作為單醯基甘油脂酶抑制劑之側氧哌□－四氫吖唉醯胺及側氧二氮呯－四氫吖唉醯胺